阿斯利康将罕见病药物组合本土化，作为其向美国承诺的500亿美元投资的一部分。

AstraZeneca will invest $2 billion to expand its presence in Maryland, its latest move to boost US manufacturing as part of a larger $50 billion pledge, the company announced Friday. The UK-based drugmaker will use ...